Clinical Trial Update: The Phase Ib Clinical Trial of the XH-S004 Tablet in Patients With Chronic Obstructive Pulmonary Disease (COPD) to Evaluate Its Safety, Tolerability, Pharmacokinetic Characteristics and Pharmacodynamic Characteristics After Multiple Administrations [Phase 1]

View source ↗

Summary

This Phase Ib trial update describes a Phase 1 study of XH-S004 Tablet in chronic obstructive pulmonary disease to evaluate safety, tolerability, pharmacokineti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• XH-S004 Tablet (XH-S004)

Snippet

Sponsor: S-INFINITY Pharmaceuticals Co., Ltd | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 1 | Status: NOT_YET_RECRUITING